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Edited by Peter BrzezinskiAbstract Blue ﬂuorescent protein from the calcium-binding
photoprotein aequorin (BFP-aq) is a complex of Ca2+-bound
apoaequorin and coelenteramide, and shows luminescence activ-
ity like a luciferase, catalyzing the oxidation of coelenterazine
with molecular oxygen. To understand the catalytic properties
of BFP-aq, various ﬂuorescent proteins (FP-aq) have been pre-
pared from semi-synthetic aequorin and characterized in com-
parison with BFP-aq. FP-aq has luciferase activity and could
be regenerated into native aequorin by incubation with coelenter-
azine. The results from substrate speciﬁcity studies of FP-aq
using various coelenterazine analogues have suggested that the
oxidation of coelenterazine by BFP-aq in the luciferase reaction
and the regeneration process to aequorin might involve the same
catalytic site of BFP-aq.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The calcium-sensitive photoprotein aequorin, isolated from
the jellyﬁsh Aequorea aequorea, has been used as a probe for
detecting calcium ions. The protein is a non-covalent complex
of apoaequorin (apoprotein, 21.4 kDa) and a hydroperoxide of
coelenterazine [1]. When Ca2+ is added, the peroxide of coelen-
terazine in aequorin decomposes into coelenteramide and CO2,
accompanied by the emission of light (kmax = 460 nm) [2–4].
After the luminescence reaction, aequorin is converted into a
blue ﬂuorescent protein (BFP-aq), a dissociable complex of
Ca2+-bound apoaequorin and coelenteramide. Apoaequorin
can be regenerated into aequorin by treatment with coelenter-
azine and molecular oxygen in the presence of ethylenedi-Abbreviations: BFP-aq, blue ﬂuorescent protein from aequorin; gFP-
aq, greenish ﬂuorescent protein from aequorin; FP-aq, ﬂuorescent
protein from semi-synthetic aequorin; FP-aq(+), Ca2+-bound form of
FP-aq; FP-aq(), Ca2+-free form of FP-aq; h-FP-aq, ﬂuorescent
protein from h-aequorin; e-FP-aq, ﬂuorescent protein from e-aequorin;
CTZ, coelenterazine; CTM, coelenteramide; EDTA, ethylenediamine-
tetraacetic acid; DTT, dithiothreitol; rlu, relative light units; SDS–
PAGE, sodium dodecylsulfate–polyacrylamide gel electrophoresis
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The regeneration process from apoaequorin to aequorin is
similar to the formation of an enzyme–substrate intermediate,
and BFP-aq can be viewed analogous to an enzyme–product
complex.
Recently, we demonstrated that BFP-aq could be prepared
eﬃciently from native aequorin and that it has a dual function
of ﬂuorescence emission and catalyzing the luminescence reac-
tion of coelenterazine [4]. Thus, blue ﬂuorescent BFP-aq has a
luciferase activity and catalyzes the oxidation of coelenterazine
like the coelenterazine luciferases of Renilla [5], Oplophorus [6],
Periphylla [7], Gaussia [8], Metridia [9] and Conchoecia [10]
specimens, as shown in the following general reaction
scheme:
CoelenterazineþO2 !luciferase Coelenteramideþ CO2 þ hm
On the other hand, upon removal of Ca2+ from BFP-aq, a
greenish ﬂuorescent protein (gFP-aq), a complex of Ca2+-free
apoaequorin and coelenteramide, is formed, and gFP-aq can
be converted into aequorin by incubating with coelenterazine
even in the absence of reducing reagent (Fig. 1) [4].
In 1988, Shimomura et al. produced semi-synthetic aequo-
rins, in which the coelenterazine moiety is replaced with vari-
ous analogues of coelenterazine [11]. The semi-synthetic
aequorins show various diﬀerent Ca2+-sensitivities and light-
emitting properties in comparison to native aequorin [12–15].
The crystal structures of semi-synthetic cp-, i-, br- and n-
aequorins were determined and found to be almost identical
with that of native aequorin [16]. Recently, the crystal struc-
tures of another photoprotein obelin (W92F mutant) [17]
and its calcium-triggered luminescence reaction product (re-
ferred to as Ca2+-discharged obelin in Ref. [18]) have been
solved, revealing that the structure of calcium-bound obelin
(W92F)–coelenteramide complex is similar to that of cal-
cium-free obelin. These structural analyses suggested that
the structure of BFP-aq might be similar to that of native
aequorin.
To investigate the catalytic site of BFP-aq involved in the
luciferase reaction and the process of regeneration to aequorin,
we prepared the ﬂuorescent protein (FP-aq) from semi-
synthetic aequorin, and examined the substrate speciﬁcities
and regeneration properties of those FP-aq with various coel-
enterazine analogues. The results obtained suggest that the
same catalytic site of BFP-aq is used for the oxidation of coel-
enterazine in the luciferase reaction and the regeneration
process, but not for the binding of coelenteramide.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Luminescence reaction of coelenterazine catalyzed by BFP-aq (A) and the formation of BFP-aq and gFP-aq from aequorin, and the
regeneration of aequorin (B). CTZ, coelenterazine; CTM, coelenteramide; CTZ-OOH, peroxide of coelenterazine.
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2.1. Materials
EDTA disodium salt, CaCl2/2H2O, (±)-dithiothreitol (DTT), ()-
quinine sulfate dihydrate and 0.1 N H2SO4 (analytical grade) were
obtained from Wako Pure Chemicals (Osaka, Japan). Coelenterazine,
h-coelenterazine and bis-coelentarazine were chemically synthesized,
and other coelenterazine analogues were kindly given by Dr. K. Tera-
nishi (Mie Universitys, Japan).2.2. Preparation of semi-synthetic aequorin
Recombinant semi-synthetic aequorin [11–15] was prepared from
the puriﬁed apoaequorin with coelenterazine analogue. Brieﬂy, apoae-
quorin was expressed in the periplasmic space of Escherichia coli strain
WA802 carrying the piP-HE expression vector [19,20], followed by
regeneration into aequorin with coelenterazine and puriﬁcation [21].
The puriﬁed aequorin (40 mg) in 10 ml of 10 mM Tris–HCl (pH 7.6)
containing 0.1 mM EDTA was luminescenced by adding 1 ml of
10 mM CaCl2, and then apoaequorin was puriﬁed by butyl-sepharose
chromatography [21]. Semi-synthetic aequorin was obtained by incu-
bation with apoaequorin and a coelenterazine analogue in 50 mM
Tris–HCl (pH 7.6) containing 30 mM EDTA and 1 mM DTT at
4 C for 24 h, and then puriﬁed as previously described [21]. The purity
of recombinant semi-synthetic aequorin on sodium dodecylsulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) analysis was over
95%.2.3. Preparation of FP-aq from semi-synthetic aequorin
The procedures for preparation of FP-aq were essentially the same
as for BFP-aq [4]. A solution of puriﬁed recombinant semi-synthetic
aequorin (8 mg) in 10 mM Tris–HCl (pH 7.6) containing 2 mM EDTA
and 1.2 M (NH4)2SO4 was concentrated to 0.2 ml using a centrifugal
concentrator, Vivaspin 2 (10000 MWCO; Sartorius AG, Germany),
at 5000 · g for 1 h at 4 C.
After adding 1 ml of 50 mM Tris–HCl (pH 7.6) containing 5 mM
CaCl2 and 1 mM DTT to the solution in the centrifugal concentrator
at 20 C, the continuous luminescence of semi-synthetic aequorin was
observed; the blue ﬂuorescence of FP-aq(+) (=Ca2+-bound form of
FP-aq) could be detected under a long wave UV lamp (kmax = 366 nm).
The FP-aq solution in the centrifugal concentrator was washed twice
with 2 ml of 50 mM Tris–HCl (pH 7.6) containing 5 mM CaCl2 and
concentrated by centrifugation using the same procedure. A quantita-
tive yield of FP-aq from semi-synthetic aequorin was obtained. For thepreparation of the Ca2+-free form of FP-aq (=FP-aq()), FP-aq(+)
was washed three times with 50 mM Tris–HCl (pH 7.6) containing
10 mM EDTA.2.4. Measurements of absorption and ﬂuorescence spectra
Absorption spectra of FP-aq were measured in 50 mM Tris–HCl
(pH 7.6) containing 10 mM CaCl2 or 10 mM EDTA with a Jasco
(Tokyo, Japan) V-560 spectrophotometer (band path 1.0 nm; response,
medium; scan speed, 200 nm/min) at 22–25 C using a quartz cuvette
(10 mm light path). The ﬂuorescence spectra were measured with a
Jasco FP-777W ﬂuorescence spectrophotometer (emission and excita-
tion band path, 1.5 nm; response, 0.5 s; scan speed, 60 nm/min), and
were corrected according to the manufacture’s instruction. Fluores-
cence quantum yields were determined relative to quinine sulfate (quan-
tum yield = 0.55, excited at 355 nm) in 0.1 M H2SO4 as a standard.2.5. Measurement of bioluminescence spectra
Luminescence spectra of recombinant semi-synthetic aequorin with
Ca2+ was measured on a Jasco FP-777 W ﬂuorescence spectrophotom-
eter (scan speed, 60 nm/min) at 22–25 C with the excitation light
source turned oﬀ.
2.6. Protein analysis
Protein concentration was determined by the dye-binding method of
Bradford [22] using a commercially available kit (Bio-Rad, Richmond,
CA) and bovine serum albumin as a standard (Pierce; Rockford, IL).
SDS–PAGE analysis was carried out under reducing conditions using
a 12% separation gel (TEFCO, Tokyo, Japan), as described by Lae-
mmli [23].
2.7. Regeneration of semi-synthetic aequorin from FP-aq
Semi-synthetic aequorin from FP-aq was obtained by incubation
with 10 lg of FP-aq and 1 lg of coelenterazine analogue in 100 ll of
50 mM Tris–HCl (pH 7.6) containing 1 mM DTT and 10 mM EDTA
at 20 C for 24 h.
2.8. Assay methods for luminescence activity
(i) Assay of luciferase activity. The total reaction mixture (100 ll)
contained coelenterazine analogue (1 lg) and 1 mM DTT in
50 mM Tris–HCl, pH 7.6. The reaction was started by addition
of protein (2 lg) and the luminescence produced was recorded
for 1 min using an Atto (Tokyo, Japan) AB2200 luminometer
S. Inouye, S. Sasaki / FEBS Letters 580 (2006) 1977–1982 1979equipped with a Hamamatsu R4220P photomultiplier. The ini-
tial intensity (Imax) of 1 ng of the puriﬁed recombinant aequorin
showed 6.4 · 104 relative light units (rlu).
(ii) Assay of semi-synthetic aequorin. After injection of 100 ll of
50 mM CaCl2 in 50 mM Tris–HCl (pH 7.6) into the regenerated
aequorin solution (0.1 lg protein), the initial intensity of the
luminescence was determined with a Labo Science (Tokyo, Ja-
pan) Model TD-4000 photometer, equipped with a Hamamatsu
R-268 photomultiplier. As the initial light intensity of e-aequorin
triggered by Ca2+ is faster than native aequorin, the accurate
intensity could not be determined with AB2200 luminometer.
The initial intensity (Imax) of 1 ng of the puriﬁed recombinant
aequorin showed 1.2 · 103 rlu.
2.9. Mass spectrometrical identiﬁcation of coelenteramide in BFP-aq
after reaction with h-coelenterazine
After the luminescent reaction of BFP-aq (0.5 mg = 23 nmol) with h-
coelenterazine (10 lg = 24 nmol in 5 ll of ethanol) in 500 ll of 50 mM
Tris–HCl (pH 7.6) containing 1 mM DTT and 1 mM CaCl2 for 24 h at
20 C, the reaction mixture was concentrated by Vivaspin column and
then washed with 2 ml of the reaction buﬀer. The concentrated protein
solution with blue ﬂuorescence and the eﬄuent fraction without ﬂuo-
rescence were separately extracted with 300 ll of ether three times.
The extracts of respective fraction were combined and dried in vacuo
and then dissolved in methanol. Coelenteramide and h-coelenteramide
in the extract were determined with a TSQ-700 triple quadruple mass
spectrometer (Thermo-Quest Finnigan Mat, San Jose, CA, USA)
equipped with an electrospray ion source. The sample was introduced
into the electrospray ion source at a rate of 10 ll/min. The analytical
conditions were as follows: mode, positive; spray voltage, 4.5 kV; elec-
tron multiplier, 1000 V; manifold vacuum, 4.09 · 106 Torr; scan
range, m/z 350–550; scan time, 1 s.3. Results and discussion
3.1. Preparation of ﬂuorescent protein from semi-synthetic
aequorin
The ﬂuorescent protein from semi-synthetic aequorin (FP-
aq) was produced according to the preparation method of
BFP-aq from native aequorin, as previously described [4].
Brieﬂy, highly concentrated aequorin in a centrifugal concen-
trator was reacted slowly with Ca2+, resulting in a blue lumi-
nescence band that lasted over 24 h. The blue ﬂuorescent
protein was obtained quantitatively (Fig. 2). In the present
study, semi-synthetic h-aequorin and e-aequorin [11–15] wereFig. 2. Photographs of recombinant aequorin and the formation of blue ﬂuor
40 mg protein per ml), (B) blue bioluminescence of recombinant aequorin la
long wave UV lamp (366 nm).chosen and converted into h-FP-aq and e-FP-aq, respectively.
h-Aequorin is a highest sensitivity calcium indicator at the low
free calcium concentration of around 107–106 M, whereas e-
aequorin shows an emission spectrum (kmax = 425 nm) diﬀer-
ent from native aequorin (kmax = 460 nm). The Ca2+-bound
forms of h-FP-aq and e-FP-aq are referred to as h-FP-aq(+)
and e-FP-aq(+), and the Ca2+-free form of these as h-FP-
aq() and e-FP-aq(), respectively.3.2. Spectral properties of FP-aq from semi-synthetic aequorin
The absorption spectra and the ﬂuorescence spectra of h-
and e-FP-aq in the presence or absence of Ca2+, and the slow
Ca2+-triggered luminescence spectra of h- and e-aequorins
were characterized, in comparison with BFP-aq and aequorin
(Table 1) [4]. The ﬂuorescence spectrum of h-FP-aq(+) was al-
most identical to the bioluminescence spectrum of h-aequorin
triggered with Ca2+. In the presence of EDTA, the ﬂuorescence
intensity of h-FP-aq(+) decreased (Fig. 3) and the ﬂuorescence
intensity of h-FP-aq() recovered to that of h-FP-aq(+) after
adding Ca2+(data not shown). Thus, h-FP-aq retained h-coel-
enteramide during the binding and the removal of Ca2+. On
the other hand, e-FP-aq(+) showed a red-shifted ﬂuorescence
spectrum (kmax = 423 nm) in comparison with BFP-aq
(kmax = 459 nm) and h-FP-aq(+) (kmax = 460 nm). The biolu-
minescence spectrum of e-aequorin was similar to the ﬂuores-
cence spectrum of e-FP-aq(), but not to e-FP-aq(+). The
ﬂuorescence intensity of e-FP-aq was not aﬀected in the pres-
ence and the absence of EDTA (Fig. 3). This result suggests
that the light-emitting species of e-aequorin in response to
Ca2+ can be derived from e-FP-aq(+) and e-FP-aq(). This
spectral diﬀerence may be explained by the amount of negative
charge on the amide N atom of e-coelenteramide, as previously
proposed by Shimomura [24]. As reported in 1970 [25], the bio-
luminescence quantum yield of aequorin is 0.15 at 25 C.
In our study, the ﬂuorescence quantum yields of BFP-aq,
h-FP-aq (+) and e-FP-aq(+) were 0.079, 0.092 and 0.056,
respectively. The reason for the lower value of the ﬂuorescence
quantum yields of BFP-aq than the bioluminescence quantum
yield of aequorin was unclear.escent protein from aequorin. (A) Recombinant aequorin (yellow color,
yered with 5 mM CaCl2, and (C) blue ﬂuorescence of BFP-aq under a
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Table 1
Absorption and ﬂuorescence spectra of various ﬂuorescence proteins from semi-synthetic aequorins, and bioluminescence spectra of semi-synthetic
aequorin upon slow interaction with Ca2+
Spectroscopy BFP-aqa gFP-aqa h-FP-aq(+) h-FP-aq() e-FP-aq(+) e-FP-aq()
Absorbance
kmax (nm) 281, 336 282, 336 281, 334 282, 339 282, 353 282, 351
0.1% solution (a) 2.82 (280 nm) 2.80 (280 nm) 2.83 (280 nm) 2.78 (280 nm) 2.74 (280 nm) 2.77 (280 nm)
0.1% solution (b) 0.56 (335 nm) 0.65 (335 nm) 0.55 (335 nm) 0.62 (335 nm) 0.72 (350 nm) 0.75 (350 nm)
a/b 5.0 4.3 5.1 4.5 3.8 3.7
Fluorescence
kmax (nm) 459 (ex. 335 nm) 467 (ex. 335 nm) 460 (ex. 335 nm) 472 (ex. 335 nm) 423 (ex. 355 nm) 418 (ex. 355 nm)
WHMF (nm)b 84 89 86 100 78 84
Quantum yield 0.079 0.073 0.092 0.030 0.056 0.044
Bioluminescencec (aequorin) (h-aequorin) (e-aequorin)
kmax (nm) 460 459
e 459 NDf 415, 445(s)g NDf
WHML (nm)d 84 84e 97 NDf 83 NDf
aData obtained in part from Ref. [4].
bWHMF, width at half-maximum of ﬂuorescence band.
cCa2+-triggered luminescence of aequorins.
dWHML, width at half-maximum of luminescence band.
eAequorin regenerated from gFP-aq.
fND, not determined.
gs, shoulder peak.
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Fig. 3. Fluorescence emission spectra of h-FP-aq and e-FP-aq in the
presence or absence of Ca2+, and bioluminescence spectra of h-FP-aq
and e-FP-aq upon slow interaction with Ca2+. The ﬂuorescence
emission spectra of h- and e-FP-aq(+) and the bioluminescence spectra
of h- and e-aequorins are normalized. The spectra of h- and e-FP-
aq() are shown in relative intensity corresponding to that of h- and
e-FP-aq(+), respectively.
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coelenterazine analogues
It has been demonstrated that BFP-aq is a complex of
Ca2+-bound apoaequorin and coelenteramide, and catalyzes
the oxidation of coelenterazine to emit light (Fig. 1) [4]. To
characterize the catalytic properties of Ca2+-bound FP-aq,
the substrate speciﬁcities of h-FP-aq(+) and e-FP-aq(+) were
examined using coelenterazine and its analogues (Fig. 4). As
summarized in Table 2, h-coelenterazine (h-CTZ) was a pre-
ferred substrate over coelenterazine for h-FP-aq(+) and e-FP-
aq(+), like in the case of BFP-aq. Presumably, the p-hydroxy
group of the C2-hydroxylbenzyl moiety of coelenterazine may
interfere with the interaction at the catalytic site of BFP-aq.
On the other hand, BFP-aq and FP-aq(+) could not utilize bis-
deoxycoelenterazine (bis-CTZ), C6-methoxyphenylcoelenter-
azine (MeO-CTZ) and e-coelenterazine (e-CTZ) as substrates
(Table 2). Thus, in the luciferase reaction, the p-hydroxy group
on the C6-hydroxylphenyl group of coelenterazine would be
essential for recognizing the substrate, and the rotation of the
C6-hydroxylphenyl group along the C–C connection bond
would be necessary for ﬁtting the substrate to the catalytic site
of BFP-aq.3.4. Luciferase reaction of BFP-aq with h-coelenterazine
In testing whether the coelenteramide in BFP-aq can be re-
placed by another coelenteramide (oxyluciferin) that is pro-
duced in a luciferase reaction of BFP-aq with a
coelenterazine, h-coelenterazine was chosen as a substrate;
the oxidation product of h-coelenterazine is h-coelenteramide.
If BFP-aq that contains coelenteramide is converted to h-FP-
aq containing h-coelenteramide in the luciferase reaction with
h-coelenterazine, it shows that coelenteramide in BFP-aq is re-
placed with h-coelenteramide. After the luminescence reaction
of BFP-aq with h-coelenterazine, the presence of coelentera-
mide and h-coelenteramide was determined by mass spectrom-
etry. The mass spectra of the extracts from the ﬂuorescent
protein showed the presence of coelenteramide (m/z = 412.3,
Table 3
Regeneration of semi-synthetic aequorins from BFP-aq, h-FP-aq(+)
and e-FP-aq(+) with coelenterazine analogues
Fluorescent
proteins
Coelenterazine
analogues
Regenerated
aequorin-types
Luminescence
activity (Imax, %)
BFP-aq CTZ aequorin 100.0
h-CTZ h-aequorin 96.7
e-CTZ e-aequorin 27.2
h-FP-aq CTZ aequorin 104.6
h-CTZ h-aequorin 96.5
e-CTZ e-aequorin 25.7
e-FP-aq CTZ aequorin 91.1
h-CTZ h-aequorin 82.6
e-CTZ e-aequorin 20.1
Table 2
Substrate speciﬁcity of BFP-aq, h-FP-aq(+) and e-FP-aq(+) to
coelenterazine analogues
Substrates: CTZ Luciferase activity (Imax, %)
and analoguesa
BFP-aq h-FP-aq(+) e-FP-aq(+)
CTZ 100.0b 69.5 69.7
h-CTZ 175.1 189.2 158.6
e-CTZ 0.3 0.3 0.1
Bis-CTZ 0.1 0.1 0.0
MeO-CTZ 0.1 0.0 0.0
aChemical structures were shown in Fig. 4.
b1.3 · 1010 rlu/s/lg protein.
S. Inouye, S. Sasaki / FEBS Letters 580 (2006) 1977–1982 1981calc. mass for [M + H]+ = 412.2). On the other hand, the eﬄu-
ent fraction had only h-coelenteramide (m/z = 396.4, calc. mass
for [M + H]+ = 396.2). Thus, we concluded that coelentera-
mide in BFP-aq was not replaced by h-coelenteramide (oxyluc-
iferin) during the luciferase reaction with h-coelenterazine
(Fig. 5). These results suggest that the catalytic site for oxida-
tion of coelenterazine is diﬀerent from the binding site of coel-
enteramide in BFP-aq.3.5. Regeneration of aequorin from FP-aq(+) with
coelenterazine analogues
In the presence of EDTA, the bound-Ca2+ is released from
BFP-aq and BFP-aq is converted to gFP-aq with greenish ﬂuo-
rescence (Fig. 1B) [4]. By incubation of gFP-aq with coelenter-
azine and molecular oxygen at 20 C in the presence and the
absence of EDTA, aequorin can be regenerated, replacing
coelenteramide in BFP-aq with the peroxide of coelenterazine
(Fig. 1B) [4]. To investigate the possibilities of conversion from
FP-aq to semi-synthetic aequorins, coelenterazine analogues
were examined with BFP-aq, h-FP-aq and e-FP-aq. As shown
in Table 3, BFP-aq, h-FP-aq and e-FP-aq could be regenerated
into aequorin quantitatively with coelenterazine and also to h-
aequorin eﬃciently with h-coelenterazine. It is of interest that
e-FP-aq was converted to e-aequorin with only 20–30% eﬃ-
ciency. However, e-FP-aq(+) did not show a signiﬁcant lumi-
nescence activity with e-coelenterazine (Table 2). These
results suggest that the conformation of the catalytic site in
e-FP-aq(+) and e-FP-aq() may diﬀer from others. On the
other hand, bis-coelenterazine and MeO-coelenterazine were
not able to form active semi-synthetic aequorins at all. Thus,
the p-hydroxy group in the C6-hydroxylphenyl group of coel-
enterazine is essential for the regeneration to aequorin from
FP-aq(), as well as for the luciferase activity. These results
from the substrate speciﬁcity of luciferase reaction and theCa2+
Ca2+
Ca2+
CTM
SH
SH
SH
CTM
h-CTM
, CO2X
h-CTZ
(Luciferin
analogue)
BFP-aq
= Luciferase
[M + H]+ = 412.2
[M + H]+ = 396.2
Fig. 5. Luminescence reaction of BFP-aq with h-coelenterazine.
h-CTZ, h-coelenterazine; h-CTM, h-coelenteramide; CTM, coelen-
teramide.regeneration reactions with various coelenterazine analogues
suggested that the same catalytic site might be involved in
BFP-aq for the oxidation of coelenterazine.
In conclusion, the ﬂuorescent proteins from semi-synthetic
aequorins were prepared quantitatively. The calcium bound
form of FP-aq can function as a luciferase, like BFP-aq from
native aequorin, showing the luminescence activities with
coelenterazine and h-coelenterazine. During the luciferase
reaction with coelenterazine, the original coelenteramide in
BFP-aq might be retained and not replaced with the oxidized
product (a coelenteramide). The regeneration of aequorin and
semi-synthetic aequorins from FP-aq can be performed, sug-
gesting that the catalytic site for the oxidation of coelenter-
azine in BFP-aq might be diﬀerent from the binding site of
coelenteramide.
Acknowledgements: The authors thank Dr. M. Nakamura for mass
spectrometry. This study was supported in part by the Program for
Promotion of Fundamental Studies in Health Science of the National
Institute of Biomedical Innovation (NIBIO) of Japan.References
[1] Head, J.F., Inouye, S., Teranishi, K. and Shimomura, O. (2000)
Nature 405, 372–376.
[2] Shimomura, O. and Johnson, F.H. (1976) Symp. Soc. Exp. Biol.
30, 41–54.
[3] Johnson, F.H. and Shimomura, O. (1978) Methods Enzymol. 57,
271–291.
[4] Inouye, S. (2004) FEBS Lett. 577, 105–110.
[5] Lorenz, W.W., McCann, R.O., Longiaru, M. and Cormier, M.J.
(1991) Proc. Natl. Acad. Sci. USA 88, 4438–4442.
[6] Inouye, S., Watanabe, K., Nakamura, H. and Shimomura, O.
(2000) FEBS Lett. 481, 19–25.
[7] Shimomura, O., Flood, Per R., Inouye, S., Bryan, B. and
Shimomura, A. (2001) Biol. Bull. 201, 339–347.
[8] Verhaegen, M. and Christopoulos, T.K. (2002) Anal. Chem. 74,
4378–4385.
[9] Markova, S.V., Golz, S., Frank, L.A., Kalthof, B. and Vysotski,
E. (2004) J. Biol. Chem. 279, 3212–3217.
[10] Oba, Y., Tsuduki, H., Kato, S., Ojika, M. and Inouye, S. (2004)
ChemBioChem 5, 1495–1499.
[11] Shimomura, O., Musicki, B. and Kishi, Y. (1988) Biochem. J. 251,
405–410.
[12] Shimomura, O., Musicki, B. and Kishi, Y. (1989) Biochem. J. 261,
913–920.
[13] Shimomura, O., Inouye, S., Musicki, B. and Kishi, Y. (1990)
Biochem. J. 270, 309–312.
1982 S. Inouye, S. Sasaki / FEBS Letters 580 (2006) 1977–1982[14] Shimomura, O., Kishi, Y. and Inouye, S. (1993) Biochem. J. 296,
549–551.
[15] Shimomura, O., Musicki, B., Kishi, Y. and Inouye, S. (1993) Cell
Calcium 14, 373–378.
[16] Toma, S., Chong, T.C., Nakagawa, A., Teranishi, K., Inouye, S.
and Shimomura, O. (2005) Protein Sci. 14, 409–416.
[17] Deng, L., Vysotski, E.S., Liu, Z.J., Markova, S.V., Malikova,
N.P., Lee, J., Rose, J. and Wang, B.C. (2001) FEBS Lett. 506,
281–285.
[18] Deng, L., Markova, S.V., Vysotski, E.S., Liu, Z.J., Lee, J.,
Rose, J. and Wang, B.C. (2004) J. Biol. Chem. 279, 33647–
33652.[19] Inouye, S., Noguchi, M., Sakaki, Y., Takagi, Y., Miyata, T.,
Iwanaga, S., Miyata, T. and Tsuji, F.I. (1985) Proc. Natl. Acad.
Sci. USA 82, 3154–3158.
[20] Inouye, S., Aoyama, S., Miyata, T., Tsuji, F.I. and Sakaki, Y.
(1989) J. Biochem. 105, 474–477.
[21] Shimomura, O. and Inouye, S. (1999) Protein Expr. Purif. 16,
91–95.
[22] Bradford, M.M. (1976) Anal. Biochem. 72, 248–254.
[23] Laemmli, U.K. (1970) Nature 227, 680–685.
[24] Shimomura, O. (1995) Biochem. J. 306, 537–543.
[25] Shimomura, O. and Johnson, F.H. (1970) Nature 227,
1356–1357.
